Tenderwize
Wróć do wyszukiwania

Epinephrine (ATC C01CA24)

AOK - Die Gesundheitskasse in Hessen·Bad Homburg, Germany·Deadline Dec 01, 2026 · 98 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)

38/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

38 / 100

Złożoność

42 / 100

Czynniki ryzyka

Structured data says electronic submission is not allowed, while the XML notice text says prior electronic submission b...

The XML notice text states that the Epinephrin procedure is withdrawn/terminated on 28.02.2026, which may affect whethe...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Jan 2027
  • Conclusion of non-exclusive rebate agreements under §130a(8) SGB V for finished medicinal products with various active substances or combinations.
  • Open-house model: accession/contract conclusion possible at any time under identical conditions.
Pokaż pełne podsumowanie

This is an open-house notice for non-exclusive rebate agreements under §130a(8) SGB V for pharmaceutical products (CPV 33600000) in Germany, led by AOK - Die Gesundheitskasse in Hessen. The notice states that accession/contract conclusion is possible at any time on the same conditions, with no individual negotiations. One lot is explicitly identified: Epinephrin (ATC C01CA24), but the lot is also stated to be withdrawn/terminated on 28.02.2026. No contract value is provided. Electronic submission is not allowed; the XML text indicates prior email submission to the buyer contact, which is an inconsistency to note.

Ryzyka

Structured data says electronic submission is not allowed, while the XML notice text says prior electronic submission b...

The XML notice text states that the Epinephrin procedure is withdrawn/terminated on 28.02.2026, which may affect whethe...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Administrative

  • Submission language is German.
  • Electronic submission is not allowed according to structured data.
  • The XML notice states prior electronic submission by email to [email protected], which conflicts with the structured electronicSubmission flag.

Zamawiający

Lokalizacja

Bad Homburg, DEU

Identyfikator

DE114110216

Działalność

Health

Części (1)

LOT-0003

Epinephrine (ATC C01CA24)

Open-house rebate agreement for the active substance Epinephrin. The lot is explicitly stated in the XML notice text as being withdrawn/terminated on 28.02.2026, despite also showing a start date of 01.02.2025 and an end date of 31.01.2027 in the structured data. Source: structured data and XML notice text.

SuppliesEU fundedElectronic submission

Lokalizacja

Germany

Czas trwania

Jan 2025 - Jan 2027

Kategoria

Pharmaceutical products

Termin

Deadline Dec 01, 2026

Szczegóły zamówienia

Data publikacji
22 Jan 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
51271-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3